contents area
Public Health Weekly Report
detail content area
The operational results of the Institutional Review Board (IRB) of the Korea Centers for Disease Control and Prevention, 2018
- Date2019-05-16 19:47
- Update2019-11-19 19:12
- DivisionDivision of Strategic Planning for Emerging Infectious Diseases
- Tel043-719-7271
The operational results of the Institutional Review Board (IRB) of the Korea Centers for Disease Control and Prevention, 2018
Lee Ho-dong, Son soonyoung, Han Rina, Son Ilyong
Division of Life Science Research Management, Center for Genome Science, KNIH, KCDC
The Institutional Review Board (IRB) of the Korea Centers for Disease Control and Prevention (KCDC) has operated under the Bioethics and Safety Act to protect the rights, safety, and welfare of human subjects. It has mainly reviewed the research proposals related to human subjects, human derivatives, embryonic stem cell lines, and bio-banking. The
Secretariat, established in the Division of Life Science Research Management, oversees operations of the IRB per standard operating guidelines. The Secretariat supports IRB works establishing protective measures for vulnerable research subjects, and preparing ethical guidelines for researchers. In 2018, the IRB held 12 sessions for six regular and six fast-track reviews, and went through a total of 124 proposals, including nineteen paper reviews. To promote the awareness of bioethics and safety among researchers, the IRB has conducted two kinds of educational programs: 67 completed off-line training course and 8,271 completed on-line training course. In addition, the IRB distributed the revised standard operating guidelines and a new guide-book for major bioethics and regulations that researchers ought to follow. The Secretariat is striving for the efficient operation of IRB.
Keywords: Institutional Review Board, Bioethics, Research Subjects, Humans, Ethical guideline
Lee Ho-dong, Son soonyoung, Han Rina, Son Ilyong
Division of Life Science Research Management, Center for Genome Science, KNIH, KCDC
The Institutional Review Board (IRB) of the Korea Centers for Disease Control and Prevention (KCDC) has operated under the Bioethics and Safety Act to protect the rights, safety, and welfare of human subjects. It has mainly reviewed the research proposals related to human subjects, human derivatives, embryonic stem cell lines, and bio-banking. The
Secretariat, established in the Division of Life Science Research Management, oversees operations of the IRB per standard operating guidelines. The Secretariat supports IRB works establishing protective measures for vulnerable research subjects, and preparing ethical guidelines for researchers. In 2018, the IRB held 12 sessions for six regular and six fast-track reviews, and went through a total of 124 proposals, including nineteen paper reviews. To promote the awareness of bioethics and safety among researchers, the IRB has conducted two kinds of educational programs: 67 completed off-line training course and 8,271 completed on-line training course. In addition, the IRB distributed the revised standard operating guidelines and a new guide-book for major bioethics and regulations that researchers ought to follow. The Secretariat is striving for the efficient operation of IRB.
Keywords: Institutional Review Board, Bioethics, Research Subjects, Humans, Ethical guideline
This public work may be used under the terms of the public interest source + commercial use prohibition + nonrepudiation conditions